Xenetic Biosciences Inc

NASDAQ XBIO

Data sourced from iex and EODHD
Download Data

Xenetic Biosciences Inc Income Statement 2011 - 2024

This table shows the Income Statement for Xenetic Biosciences Inc going from 2011 until 2024. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30
Revenue
M 2 3 2 2 2 2 2 1 1 1 1 1 1 0 0 0 0 0 0 0 0 8 15 15 15 8 3 3 3 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Cost of Revenue
M - - - - - - - - - - - - - - - - - - 0 0 0 0 0 0 0 3 6 8 12 11 8 6 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - -
Gross Profit
M 2 3 2 2 2 2 2 1 1 1 1 1 1 0 0 0 0 0 0 0 0 8 15 15 15 7 3 3 3 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Expenses
M 7 7 7 7 8 8 9 9 7 7 6 15 15 14 14 4 3 1 2 3 5 15 16 17 17 11 11 11 51 50 50 52 10 12 14 13 14 13 9 6 3 0 0 0 0 0 0 0 0 0 0
Selling, General, and Administrative Expenses (SG&A)
M 3 4 3 4 4 4 4 4 4 4 4 4 3 3 3 5 5 5 5 4 4 4 5 6 6 7 7 7 7 7 6 8 7 7 7 5 6 7 5 4 3 0 0 0 0 0 0 0 0 0 0
Research and Development (R&D) Expenses
M 4 3 4 3 4 5 5 5 4 3 2 2 2 2 2 5 5 5 5 2 3 3 3 4 4 4 4 4 45 44 44 44 3 5 7 8 9 6 4 2 1 - - - - - - - - - -
Other Operating Expenses
M 0 0 0 0 0 0 0 0 0 0 0 9 9 9 9 0 0 0 0 0 0 8 7 7 7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - - - - - - - -
Costs and Expenses
M - - - - - - - - - - - - - - - - - - 2 3 5 7 9 9 10 8 5 3 40 40 42 46 8 12 14 13 14 13 9 6 3 0 0 0 0 0 0 0 0 - -
Operating Income
M -5 -5 -5 -5 -6 -7 -7 -8 -6 -6 -5 -14 -14 -14 -14 -12 -13 -13 -13 -6 -7 -7 -1 -2 -3 -4 -8 -8 -48 -47 -50 -52 -10 -12 -14 -13 -14 -13 -9 -6 -3 0 0 0 0 0 0 0 0 0 0
Interest Expense
M 0 0 0 0 0 0 0 0 0 0 0 19 19 19 19 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Non-operating Income/Expense
M 0 0 0 0 0 0 0 0 0 0 0 -9 -9 -9 -9 -3 -3 -3 -3 0 0 0 0 0 0 0 0 0 -5 -6 -7 -8 -3 -2 -1 0 0 -1 -1 -1 -1 0 0 0 0 0 0 0 0 0 0
EBT
M -4 -4 -4 -4 -6 -7 -7 -7 -6 -6 -5 -14 -14 -14 -14 -12 -13 -13 -13 -6 -7 -7 -1 -2 -3 -4 -8 -9 -54 -54 -57 -60 -14 -14 -15 -13 -15 -14 -10 -7 -4 0 0 0 0 0 0 0 0 0 0
Income Tax Provision
M 0 0 0 0 0 0 0 0 0 0 0 -3 -3 -3 -3 6 6 6 7 0 0 0 0 0 0 0 0 0 5 6 7 8 4 2 1 0 0 1 1 1 1 0 0 0 0 0 0 0 0 0 0
Income after Tax
M -4 -4 -3 -3 -6 -6 -7 -7 -6 -6 -5 -11 -11 -11 -11 -19 -19 -19 -20 -6 -7 -7 -1 -2 -3 -4 -9 -9 -58 -60 -64 -68 -17 -17 -16 -13 -15 -16 -11 -8 -5 0 0 0 0 0 0 0 0 0 0
Non-Controlling Interest
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 5 5 4 4 0 11 11 11 11 4 4 4 4 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - - - - - -
Net Income
M -1 -2 -3 -4 -5 -6 -7 -7 -6 -6 -5 -11 -11 -11 -11 -14 -14 -18 -19 -10 -11 -7 -1 -2 -3 -4 -66 -66 -111 -112 -66 -69 -23 -21 -23 -21 -23 -24 -10 -7 -4 0 0 - - - - - - - -
Shares (Basic, Weighted)
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Shares (Diluted, Weighted)
R 1,533,779.25 1,527,773.00 4,699,601.50 7,895,600.50 11,031,064.50 14,011,914.00 12,996,348.25 9,671,253.25 6,373,277.25 3,231,919.50 2,877,943.50 2,781,295.00 2,719,836.50 2,657,013.25 2,028,780.25 1,967,948.00 1,832,791.75 1,697,132.75 340,491.25 263,514.50 259,685.00 257,672.00 237,595.25 236,160.00 236,075.00 235,661.00 231,521.25 232,083.00 230,203.50 222,021.50 140,195.50 130,282.75 122,818.50 201,193.00 193,484.00 193,262.75 193,057.50 113,706.75 26,619.25 26,552.75 18,816.00 11,079.25 11,079.25 11,079.25 10,992.75 10,771.75 16,232.50 8,341.25 10,100.67 13,888.50 2,525.00
EBITDA
M -5 -5 -5 -5 -6 -7 -7 -8 -6 -6 -5 4 4 5 5 -6 -6 -6 -7 -6 -7 -7 -1 -2 -2 -4 -8 -8 -48 -47 -50 -52 -10 -12 -14 -13 -14 -13 -9 -6 -3 0 0 0 0 0 0 0 0 0 0
Depreciation and Amortization
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
EBIT
M -5 -5 -4 -4 -6 -7 -7 -8 -6 -6 -5 4 4 5 5 -6 -6 -6 -7 -6 -7 -7 -1 -2 -3 -4 -8 -8 -48 -47 -50 -52 -10 -12 -13 -13 -14 -13 -9 -6 -3 0 0 0 0 0 0 0 0 0 0
Income from Discontinued Operations
M - - - - - - - - - - - - - - - - - - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - - - - - - - -
Tax Rate (Effective)
% 5.03 6.97 8.62 6.34 5.04 4.15 2.90 2.01 2.19 1.81 1.31 7.81 8.09 8.75 10.19 -15.09 -15.83 -16.92 -18.30 0.05 -0.37 -0.29 -0.37 -0.57 -0.38 -0.55 -18.83 -17.43 -19.52 -29.76 -16.91 -24.69 -19.94 -10.15 -4.64 1.34 -2.27 -8.32 -10.04 -14.04 -19.01 -7.18 -10.98 -8.27 -4.22 -12.19 -8.90 -12.56 -14.69 -18.45 -18.45
Earnings Per Share (EPS), Basic
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Earnings Per Share (EPS), Diluted
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - - - - - -
Gross Profit Margin
% 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 - - - 100.00 99.61 61.69 61.69 42.53 42.92 100.00 100.00 100.00 - - - - - - - - 100.00 38.24 50.43 60.13 51.08 81.96 81.46 78.16 87.21 87.21 92.01 100.00 100.00
Operating Income Margin
% -201.71 -177.40 -210.94 -215.20 -330.39 -396.73 -457.33 -504.66 -441.47 -516.37 -577.06 -2,743.74 -2,863.21 -3,226.42 -4,833.81 -3,424.86 -4,702.29 -7,235.76 - - - -24.38 17.35 -867.06 -867.06 -1,288.40 -1,319.01 -2.15 -2.15 -2.15 - - - - - - - - -3,539.28 -1,382.84 -930.63 -683.96 192.30 -38.78 -56.67 -88.80 -98.36 -87.63 -84.24 -90.12 -107.77
Net Income Margin
% -161.44 -151.41 -172.88 -178.18 -298.14 -365.21 -449.69 -497.86 -433.74 -507.29 -567.11 -2,100.73 -2,215.65 -2,559.26 -4,075.31 -3,260.00 -4,467.75 -6,857.18 - - - -24.30 17.48 -873.01 -873.01 -1,297.37 -2,297.69 -1,941.38 -1,941.38 -1,941.38 - - - - - - - - - 954.93 954.93 954.93 954.93 - - - - - - - -
EBITDA Ratio
% -201.71 -177.40 -210.94 -214.72 -329.34 -395.06 -454.97 -502.13 -438.76 -513.17 -573.22 1,247.18 1,128.52 767.48 -830.27 -3,403.77 -4,673.80 -7,191.86 - - - -24.30 17.52 -864.86 -864.86 -1,285.14 -1,315.73 -1.84 -1.84 -1.84 - - - - - - - - -2,696.36 -1,035.63 -694.66 -502.91 166.66 -22.31 -39.93 -72.45 -82.35 -70.16 -65.80 -69.85 -82.01
EBIT Ratio
% -201.32 -178.06 -217.72 -213.62 -328.82 -395.34 -457.33 -504.66 -441.47 -516.37 -577.06 1,242.64 1,123.16 759.96 -847.44 -3,424.86 -4,702.29 -7,235.76 - - - -24.38 17.45 -866.99 -866.99 -1,288.30 -1,319.01 -2.15 -2.15 -2.15 - - - - - - - - -3,539.28 -1,316.49 -886.39 -650.79 225.48 -38.78 -56.67 -88.80 -98.36 -87.63 -84.24 -90.12 -107.77
EBT Ratio
% -185.61 -162.47 -194.99 -200.34 -320.29 -387.37 -449.69 -497.86 -433.74 -507.29 -567.11 -2,730.08 -2,845.00 -3,188.61 -4,704.66 -3,260.00 -4,467.75 -6,857.18 - - - -24.30 17.49 -873.01 -873.01 -1,297.36 -1,333.52 -13.04 -13.04 -13.04 - - - - - - - - -3,801.84 -1,427.67 -963.35 -710.93 228.55 -48.79 -66.78 -98.70 -108.06 -100.38 -98.29 -106.76 -132.15

StockViz Staff

September 19, 2024

Any question? Send us an email